Skip to main content

3SBio

3SBio Inc is a China-based biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of biological therapies. The company specializes in biopharmaceutical products across core therapeutic areas, including nephrology, oncology, rheumatology, and dermatology. Its primary revenue drivers are sales of proprietary biopharmaceutical drugs such as TPIAO for thrombocytopenia and EPIAO for anemia, alongside dermatological products. The principal end markets serve hospitals, healthcare professionals, and patients throughout mainland China and select export markets. 3SBio maintains a leading domestic market position in China for recombinant protein therapeutics. 3SBio Inc is headquartered in Shenyang, China, and its shares are listed on the Hong Kong Stock Exchange under the ticker 1530.

20 of the funds FundTelligence covers report a position in 3SBio.

Legal name
3SBio Inc
Sector
Health Care
Country
China
Funds holding it
20

Funds holding 3SBio

Showing the 8 largest of 20 funds holding it.

Loading...